What will happen to the dengue virus in Buenos Aires City?

Argentina is transiting a historical brother dengue fever, PUSH virus infection broadcasting in the el region mosquito aedes aegypti, which continues to apply to the health authorities of the citizens of 19 to 24 national jurisdictions. In Argentina, ANMAT approved a vacuum against diseases in April 2023 and the national government advised to follow the guidelines WHO/PAHO that “in fact no recommendation which is included” in the national immunization programs for its free use, a provision also observed by the health authorities of the city of Buenos Aires.

En Argentina, last Bulletin Epidemiológico Nacional stated that from the 31st week of 2023 – the end of July and the beginning of August – until the 10th week of 2024 – the beginning of March – “will be registered 120,007 dengue cases: 109,313 before the trip (autonomous), 3,917 imported and 6,777 under investigation, resulting in an accident accumulated to the level of 255 cases for every thousand inhabitants”.

Before these figures are given, people have many questions about one of the available means of preventing the disease: new Dengue vaccine opens for ANMAT in 2023.

The Minister of Health of the City of Buenos Aires, to clarify at this time its convenience and use, Fernan Quiros I explained why it is not in massive form and when it might change in a radio interview.

“Vacuum has been on the market for a year” I say, but due to the short time since the application began, you know that “it is safe and effective, because until ANMAT is approved” further “it has no effect on opponents other than any other vacuum”. In addition, it “shows the effectiveness of children, adolescents and young people”, Radio Rivadavia said in the dialogue.

“We suspect that the way vacuum is demonstrated in young people is appropriate for young adults. however probably the effectiveness in people over 60 is not the same and we do not know if it is sufficient or not“, stated Quirós, that is, “It seems clear that it is indicated for young people in the high circulation areas that are endemic today”.

“My personal position – I noticed – is that in these months we want to have much more accurate information about who is released, how to vaccinate in other places” but “for the city of Buenos Aires I want to recommend it every day Nowadays I don’t have no info to recommend. How Dengue in the city is an epidemic and does not have a permanent circulation (Editor’s note: this will be endemic), we need a little more information than I hope June or July and so let us prepare for the approaching bell of war, for this is the disease that comes to the city of all the townspeople. So we can tell them to the door company and clearly tell people if they don’t recommend it.’

They also refer people who are suffering from dengue fever and a vacuum is recommended. “Technically speaking, if we talk about vacunar ‘sucio’, it is decided, vacunar all or vacunar with a previous serological test, because whoever decides that “you have dengue” does not need this strategy because 70% of those who have dengue are asymptomatic and do not know to detect it. So, if you want to vaccinate those who have dengue, please do a diagnostic test first and then vaccinate, what does that do? vacancy campaigns are practically unfeasible in all parts of the world, why in some cases it leads a vacunación campaign with previous serology. If you have tried hepatitis B virus but it is very complete”.

And he finished: “I have done the work of revising the entire bibliography from ’78 to this section, which shows the importance of the increase in risk second day that a person has dengue fever, and there are two types of bibliography that analyze immunological phenomena and provide a possible or plausible explanation for the second I could be more pregnant“.

“There is some published experience that suggests it is. Cuban brother with dengue fever from 81 and his relationship with 5 children who saw him twice. And dengue from Southeast Asia. Cuban dengue fever has very little impact,” the minister said.

But from the latest bibliography, “there is what they say contrary, It is clear that such a stark difference in pre-infection severity cannot be encountered a second time, based on a study published in Nature of cases in India, the country with the highest incidence of dengue in the world. The investigators published and demonstrated that children who caught dengue for the first time compared to those who caught it a second time They could not meet with a distinct gravity in those who saw it a second time“, he therefore believed that the recurrence of the contagion “is not the serious thing that the whole world is getting from all sides, and it is probably serious if it is similar to when one is older than life or has a co-morbidity”.

“Dengue mortality is very low, not exceeding 0.2 or 0.3%, and the international rate is also low. “The problem is that people who are inside obviously have a higher chance of getting complicated, but there is no comparison, neither with the virus nor with COVID, in terms of mortality,” the door official concluded.

Sources of the Ministerio de Salud de la Nación consulted Infobae reiterated that “respect for the dengue vacuum, Currently, PAHO/WHO does not recommend that dengue infection be included in a country’s national immunization programs”, so it is not part of the National Holiday Calendar today.

“After numerous reviews with scientific societies and representatives of the academic sectors of infectology, the Ministry of Health of the nation concluded that in such a broad context as the current one, the vacuum This is not recommended as a public health strategy to prevent the spread of disease,” they said.

Y highlighted: “The Ministry of Health continues to work intensively to achieve the most convenient and appropriate health care, that a health solution to the problem of this disease, which is endemic in the country from 2023, and analyzing scientific evidence to determine the benefit of an immunization program in the most affected areas”.

As for the dengue vacuum, it is available in Argentina National Administration of Medicines, Food and Medical Technology (ANMAT) in April 2023, currently OPS is not recommended for inclusion in country immunization programs.

Without embargo, en Specific subnational geographic areas when considering the introduction of a vacuum, its implementation must be accompanied by careful measures to guarantee the evaluation, monitoring of the safety and effectiveness of the vacuum; as well as affected communities and health workers are fully informed of the potential benefits and risks.

At the moment, the strategy recommended by the Ministry of Health and OPS/WHO for the prevention and control of mosquito-borne diseases continues to focus on collaboration between community and health teams, if subrayó.

Key actions include mosquito transmitter control, bite preventiontimely and adequate attention to cases and constant compromises of communities.

Integrated and simultaneous implementation of these measures will reduce the risks associated not only with dengue but also with other mosquito-borne diseases such as zika and chikungunya.